PRRT (Peptide Receptor Radionuclide Therapy)

A Contract Award Notice
by BELFAST HEALTH & SOCIAL CARE TRUST

Source: Find a Tender
Type: Contract ()
Duration: not specified
Value: £2M

Sector: MISCELLANEOUS
Published: 10 Nov 2025
Delivery: not specified
Deadline: n/a

Concepts

Location

Geochart for 1 buyers and 1 suppliers

1 buyer

Belfast Health & Social Care Trust Belfast

1 supplier

Novartis Pharmaceuticals London

Description

Procurement of PRRT (Peptide Receptor Radionuclide Therapy)

Award Detail

1	Novartis Pharmaceuticals (London) PRRT (Peptide Receptor Radionuclide Therapy) Reference: 1 Value: £1,820,000

CPV Codes

None found

Legal Justification

Under Schedule 5 of the PA2023, only one supplier can supply these goods as they have exclusive rights and hold the unique patent and licence for this product. Lutathera is a licenced radiopharmaceutical for specialised patient treatments.